Average Co-Inventor Count = 5.84
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (14 from 1,179 patents)
2. Takeda San Diego, Inc. (1 from 53 patents)
15 patents:
1. 11426397 - Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6
2. 10407409 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
3. 9944626 - 6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD
4. 9708296 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
5. 9345713 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
6. 9187497 - Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)
7. 9040522 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
8. 8822470 - Substituted pyrido[2,3-b]pyrazines
9. 8541417 - Poly (ADP-ribose) polymerase (PARP) inhibitors
10. 8450323 - Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine
11. 8318727 - Polo-like kinase inhibitors
12. 8138168 - Renin inhibitors
13. 8124606 - Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3',2′-e]pyrazin-6(6aH)-ones
14. 7928105 - Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones
15. 7759339 - Hydroxysteroid dehydrogenase inhibitors